IL-23 has a strong synergistic effect with TNF-α, IL-22, and IFN-γ, and is a key factor in the pathogenesis of arthritis and inflammatory bowel disease (Stritesky et al., 2008; Markham, 2018; Yang et al., 2021). Here, IL37 is linked to inflammatory bowel disease.